Is it safe to take 30 mg of ketorolac (Toradol) once weekly for a month?

No, taking 30 mg of ketorolac (Toradol) once weekly for a month is not safe and exceeds FDA-approved duration limits.

Ketorolac is explicitly contraindicated for chronic or intermittent use beyond 5 consecutive days, regardless of dosing frequency. The FDA drug label is unequivocal: ketorolac therapy "is not to exceed 5 days" for any indication 1. This restriction exists because ketorolac carries significant risks of gastrointestinal bleeding, renal toxicity, and cardiovascular complications that increase with cumulative exposure—even at intervals.

Why This Matters for Your Specific Scenario

While you're proposing only once-weekly dosing over a month (4 total doses), this still violates the fundamental safety principle that ketorolac is approved exclusively for acute, short-term pain management—not intermittent or recurring use 1. The 5-day maximum applies to the treatment episode, not just consecutive daily dosing.

Key Safety Concerns

Gastrointestinal Risks:

• Ketorolac significantly increases risk of peptic ulcers and GI bleeding, with risk persisting beyond the immediate dosing period 2
• Even single doses can trigger complications in susceptible individuals
• The drug has been associated with higher GI toxicity compared to other NSAIDs due to its potency and mechanism 2

Renal Toxicity:

• NSAIDs like ketorolac can cause acute kidney injury, particularly with repeated exposure 3, 4
• Risk factors include age >60 years, dehydration, pre-existing renal impairment, or concurrent nephrotoxic medications 3
• Renal effects may be cumulative even with intermittent dosing

Cardiovascular Risks:

• All NSAIDs carry cardiovascular risks that increase with duration of exposure 2
• Hypertension development or worsening is a recognized complication 3

What the Evidence Shows About Duration

The cancer pain guidelines explicitly state ketorolac should be used for "short-term use...for maximum of 5 days" 3. The FDA label reinforces this across all formulations, specifying that for multiple-dose treatment, the maximum is 5 days regardless of indication 1. Even in intensive care settings where potent analgesia is critical, ketorolac is recognized as requiring "dose adjustments with renal dysfunction" and carries "increased risk of bleeding" 5.

Research on ketorolac safety confirms that "the risk for adverse events increases with high doses, with prolonged therapy (>5 days) or in vulnerable patients" 6, 7. The incidence of serious adverse events only declined after dosage guidelines were revised to limit duration 6.

The Right Approach

For recurring weekly pain requiring intervention:

• Consider scheduled acetaminophen (up to 4000 mg/day with normal liver function) 5
• Oral NSAIDs like ibuprofen (400-800 mg every 6 hours, max 2.4 g/day) or naproxen sodium (275-550 mg every 6-12 hours) are safer for intermittent use 8, 9
• If NSAID therapy is needed chronically, use oral formulations with gastroprotection (proton pump inhibitor) and monitor renal function every 3 months 3, 9
• For neuropathic components, consider gabapentinoids 5

If pain is severe enough to consider ketorolac:

• This signals need for comprehensive pain evaluation, not repeated ketorolac dosing
• A single 30 mg dose can be used for acute flares, but not as a scheduled weekly intervention 1
• Alternative strategies include physical therapy, interventional procedures, or appropriate long-term analgesic regimens 3

Critical Contraindications to Ketorolac

Avoid ketorolac entirely if you have 1, 6:

• History of peptic ulcer disease or GI bleeding
• Renal impairment (even mild)
• Bleeding disorders or anticoagulant use
• Age ≥65 years (requires dose reduction to 15 mg if used acutely)
• Cardiovascular disease
• Aspirin or NSAID allergy
• Concurrent use of other NSAIDs

The bottom line: Ketorolac's approval is limited to acute pain management for ≤5 days. Using it weekly for a month—even with only 4 total doses—represents off-label chronic use that contradicts FDA guidance and exposes you to unnecessary risks of serious complications. Seek alternative pain management strategies appropriate for recurring or chronic pain.